We measure whether expert patients – those trained as physicians and nurses – have fewer emergency department visits and the reasons for…
This paper explores past episodes of technological disruption in the US labor market, with the goal of learning lessons about the likely…
Medicare Part D does not allow plans to exclude drugs in six protected classes from their formularies, which may limit plans’ ability to…
Recent efforts to control spending, including accountable care organizations, value-based payment, and high-deductible health plans, have…
There’s growing global interest in investing in disease prevention—not just to improve health but to cut health care costs. The idea seems…
The Inflation Reduction Act (IRA) of 2022 is the most significant reform to US prescription drug pricing in two decades and the first…
The growth in spending on health care has slowed over the last decade, easing fears that Medicare would devour the federal budget, create…
/publications/medicare-price-negotiation-and-pharmaceutical-innovation-following-inflation-reduction
The Inflation Reduction Act (IRA) requires Medicare to negotiate lower prices for some medicines with high Medicare spending. Using…
Notwithstanding concerns about staffing levels and burnout in health care, federal wage and employment data does not support the suggestion…
Importance: The Inflation Reduction Act (IRA) requires Medicare to negotiate prices for some high-spending drugs but exempts drugs approved…